Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT06759298. We help you review the study, but cannot decide medical eligibility.
Not Yet RecruitingNCT06759298
The Effects of Methylphenidate on Symptomatology in Individuals With Borderline Personality Disorder
This study is not yet recruiting. It focuses on personality disorders and currently lists study information.
Personality disorders, Borderline personalityDrugFrom 18 Years to 50 Years
Understand this study
Who could participate?
Listed age limits: 18 years to 50 years.
Compensation and expense reimbursement have not been verified for this summary.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateEstimated: January 15, 2025
- Recruitment status
- Not Yet Recruiting
- Enrollment listed in the registry
- 60
- Sponsor
- Tanta University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- EARLY Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
- Locations
- Not clearly listed
- Age range
- From 18 Years to 50 Years
- Official registry ID
- NCT06759298
- Official title
- The Effects of Methylphenidate on Symptomatology in Individuals With Borderline Personality Disorder
Recruitment & locations
Not yet recruitingLocations not listed
Registry details
Registry conditions (original wording)
Borderline Personality Disorder
Questions about this study
Who is behind this study?
The study sponsor is Tanta University, a university.
Does this study involve medication?
Yes. The study involves medication, including methylphenidate and matched placebo tablet.
Who can participate?
Listed age limits: 18 years to 50 years.
Is this study still recruiting?
The registry lists this study as not yet recruiting.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
Not Yet RecruitingNCT07833761
ADEPT Psilocybin-Assisted Therapy With DBT for Borderline Personality Disorder
This study is not yet recruiting. It focuses on personality disorders and currently lists study information in the United States.
Not Yet RecruitingNCT07099534
Ketamine Infusion for Symptomatic Improvement in Severe Borderline Personality Disorder
This study is not yet recruiting. It focuses on personality disorders and currently lists study information in France.
Not Yet RecruitingACTRN12609001013257
Methylphenidate for Borderline Personality Disorder in Adolescents
This study is not yet recruiting. It focuses on personality disorders and currently lists study information.